Literature DB >> 14585770

Evaluation of cluster randomized controlled trials in sub-Saharan Africa.

Petros Isaakidis1, John P A Ioannidis.   

Abstract

Cluster randomized controlled trials (CRCTs) are attractive in settings in which individual randomization is difficult or impossible. This issue is common when studying several health problems in developing countries. The authors aimed to assess empirically the extent to which the prerequisite design and analysis aspects of cluster randomization were taken into account and reported properly in CRCTs conducted in sub-Saharan Africa. CRCTs published in the last three decades were evaluated by using a checklist based on the Consolidated Standards of Reporting Trials (CONSORT) statement. The authors identified 51 eligible CRCTs; 40 of them (78%) had been published after 1990. Only 10 (20%) studies took clustering into account in sample size or power calculations, and only 19 (37%) took clustering into account in the analysis. Intracluster correlation coefficients and design effects were reported in only one (2%) and three (6%) trials, respectively. An increasing number of CRCTs are conducted in sub-Saharan Africa, but many are not analyzed and reported properly. The special features stemming from cluster randomization need to be addressed in the design, analysis, and reporting of these studies.

Mesh:

Year:  2003        PMID: 14585770     DOI: 10.1093/aje/kwg232

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  26 in total

1.  CONSORT statement: extension to cluster randomised trials.

Authors:  Marion K Campbell; Diana R Elbourne; Douglas G Altman
Journal:  BMJ       Date:  2004-03-20

2.  A brief history of the cluster randomised trial design.

Authors:  Jenny Moberg; Michael Kramer
Journal:  J R Soc Med       Date:  2015-05       Impact factor: 5.344

3.  Cluster randomized trials of cancer screening interventions: are appropriate statistical methods being used?

Authors:  Catherine M Crespi; Annette E Maxwell; Sheng Wu
Journal:  Contemp Clin Trials       Date:  2011-03-05       Impact factor: 2.226

4.  Electronic search strategies to identify reports of cluster randomized trials in MEDLINE: low precision will improve with adherence to reporting standards.

Authors:  Monica Taljaard; Jessie McGowan; Jeremy M Grimshaw; Jamie C Brehaut; Andrew McRae; Martin P Eccles; Allan Donner
Journal:  BMC Med Res Methodol       Date:  2010-02-16       Impact factor: 4.615

Review 5.  Internal and external validity of cluster randomised trials: systematic review of recent trials.

Authors:  Sandra Eldridge; Deborah Ashby; Catherine Bennett; Melanie Wakelin; Gene Feder
Journal:  BMJ       Date:  2008-03-25

6.  Intraclass correlation coefficients typical of cluster-randomized studies: estimates from the Robert Wood Johnson Prescription for Health projects.

Authors:  David M Thompson; Douglas H Fernald; James W Mold
Journal:  Ann Fam Med       Date:  2012 May-Jun       Impact factor: 5.166

Review 7.  Characteristics of randomized trials published in Latin America and the Caribbean according to funding source.

Authors:  Ludovic Reveiz; Stephanie Sangalang; Demian Glujovsky; Carlos E Pinzon; Claudia Asenjo Lobos; Marcela Cortes; Martin Cañón; Ariel Bardach; Xavier Bonfill
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

8.  Randomized controlled trials of malaria intervention trials in Africa, 1948 to 2007: a descriptive analysis.

Authors:  Vittoria Lutje; Annette Gerritsen; Nandi Siegfried
Journal:  Malar J       Date:  2011-03-15       Impact factor: 2.979

9.  The effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in cancer patients treated with radiotherapy: design of a cluster randomised controlled trial.

Authors:  Anna P B M Braeken; Lilian Lechner; Francis C J M van Gils; Ruud M A Houben; Daniëlle Eekers; Ton Ambergen; Gertrudis I J M Kempen
Journal:  BMC Cancer       Date:  2009-06-09       Impact factor: 4.430

10.  The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials.

Authors:  Charles Weijer; Jeremy M Grimshaw; Martin P Eccles; Andrew D McRae; Angela White; Jamie C Brehaut; Monica Taljaard
Journal:  PLoS Med       Date:  2012-11-20       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.